In this study, a recombinant chimeric protein vaccine (HG6) containing six tandem repeats of a GRP fragment (18 to 27 amino acids) fused to the 65-kDa heat shock protein (HSP65) was used to treat mice challenged with breast cancer [115]. This evidence concerns the gene GRP and breast cancer.